Eriksson, John;Paul, Preethy;Peuhu, Emilia;Akbarsha, M. A.
发明人:
申请号：
EP13792713.3
公开号：
EP2895162B1
申请日:
2013.08.28
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
